These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16081270)

  • 1. Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals.
    Henning SM; Niu Y; Liu Y; Lee NH; Hara Y; Thames GD; Minutti RR; Carpenter CL; Wang H; Heber D
    J Nutr Biochem; 2005 Oct; 16(10):610-6. PubMed ID: 16081270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
    Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
    Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
    Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
    Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS
    Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers.
    Xu JZ; Yeung SY; Chang Q; Huang Y; Chen ZY
    Br J Nutr; 2004 Jun; 91(6):873-81. PubMed ID: 15182391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.
    Lee MJ; Maliakal P; Chen L; Meng X; Bondoc FY; Prabhu S; Lambert G; Mohr S; Yang CS
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1025-32. PubMed ID: 12376503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
    James KD; Forester SC; Lambert JD
    Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement.
    Henning SM; Niu Y; Lee NH; Thames GD; Minutti RR; Wang H; Go VL; Heber D
    Am J Clin Nutr; 2004 Dec; 80(6):1558-64. PubMed ID: 15585768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans.
    Kimura M; Umegaki K; Kasuya Y; Sugisawa A; Higuchi M
    Eur J Clin Nutr; 2002 Dec; 56(12):1186-93. PubMed ID: 12494303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma.
    Nakagawa K; Okuda S; Miyazawa T
    Biosci Biotechnol Biochem; 1997 Dec; 61(12):1981-5. PubMed ID: 9438978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of co-administration of tea epigallocatechin-3-gallate (EGCG) and caffeine on absorption and metabolism of EGCG in humans.
    Nakagawa K; Nakayama K; Nakamura M; Sookwong P; Tsuduki T; Niino H; Kimura F; Miyazawa T
    Biosci Biotechnol Biochem; 2009 Sep; 73(9):2014-7. PubMed ID: 19734672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities.
    Elbling L; Weiss RM; Teufelhofer O; Uhl M; Knasmueller S; Schulte-Hermann R; Berger W; Micksche M
    FASEB J; 2005 May; 19(7):807-9. PubMed ID: 15738004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, tissue distribution and elimination of 4-[(3)h]-epigallocatechin gallate in beagle dogs.
    Swezey RR; Aldridge DE; LeValley SE; Crowell JA; Hara Y; Green CE
    Int J Toxicol; 2003; 22(3):187-93. PubMed ID: 12851151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin as a permeability enhancer enhanced the antihyperlipidemic activity of dietary green tea extract.
    Pandit AP; Joshi SR; Dalal PS; Patole VC
    BMC Complement Altern Med; 2019 Jun; 19(1):129. PubMed ID: 31196040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat.
    Nakagawa K; Miyazawa T
    J Nutr Sci Vitaminol (Tokyo); 1997 Dec; 43(6):679-84. PubMed ID: 9530620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green Tea and Bone Marrow Transplantation: From Antioxidant Activity to Enzymatic and Multidrug-resistance Modulation.
    Peluso I; Palmery M; Vitalone A
    Crit Rev Food Sci Nutr; 2016 Oct; 56(14):2251-60. PubMed ID: 26047551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemiluminescence-high-performance liquid chromatographic determination of tea catechin, (-)-epigallocatechin 3-gallate, at picomole levels in rat and human plasma.
    Nakagawa K; Miyazawa T
    Anal Biochem; 1997 May; 248(1):41-9. PubMed ID: 9177723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of human glutathione s-transferases by polyphenon e intervention.
    Chow HH; Hakim IA; Vining DR; Crowell JA; Tome ME; Ranger-Moore J; Cordova CA; Mikhael DM; Briehl MM; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1662-6. PubMed ID: 17684143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tea phenols in bulk and nanoparticle form modify DNA damage in human lymphocytes from colon cancer patients and healthy individuals treated in vitro with platinum-based chemotherapeutic drugs.
    Alotaibi A; Bhatnagar P; Najafzadeh M; Gupta KC; Anderson D
    Nanomedicine (Lond); 2013 Mar; 8(3):389-401. PubMed ID: 22943128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea extract and its major constituent epigallocatechin-3-gallate inhibit growth and halitosis-related properties of Solobacterium moorei.
    Morin MP; Bedran TB; Fournier-Larente J; Haas B; Azelmat J; Grenier D
    BMC Complement Altern Med; 2015 Mar; 15():48. PubMed ID: 25880992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.